Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2026-01-27 @ 3:29 AM
Study NCT ID:
NCT00137761
Status:
COMPLETED
Last Update Posted:
2009-11-02
First Post:
2005-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
04-173
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Matthew Kulke, MD
Old Organization:
Dana-Farber Cancer Institute